What are the normal levels for normetanephrines (NMN), a metabolite of norepinephrine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Normal levels for normetanephrines vary slightly depending on the laboratory and testing method used, but generally, plasma free normetanephrine levels should be less than 0.9 nmol/L (approximately 164 pg/mL) and for 24-hour urine collections, normal normetanephrine levels are typically below 900 μg/24 hours, as updated reference intervals have been proposed to reduce false positives without compromising test sensitivity for true pheochromocytoma 1.

Key Points to Consider

  • The updated reference intervals for urine normetanephrine aim to minimize false positives while maintaining test sensitivity for pheochromocytoma diagnosis 1.
  • Plasma free normetanephrine levels and 24-hour urine collections are used to diagnose conditions such as pheochromocytoma, paraganglioma, or other catecholamine-secreting tumors.
  • Certain factors can falsely elevate normetanephrine levels, including stress, strenuous exercise, certain medications, caffeine consumption, and alcohol withdrawal.
  • Patients should avoid these potential interfering factors before testing when possible to ensure accurate results.
  • If elevated levels are found, repeat testing or additional diagnostic procedures may be recommended to confirm findings.

Relevant Guidelines and Studies

  • The Endocrine Society clinical practice guideline recommends initial biochemical testing for pheochromocytoma and paraganglioma (PPGL) to include measurements of plasma free or urinary fractionated metanephrines, considering preanalytical factors that may lead to false-positive or false-negative results 2.
  • A study found that plasma free metanephrine and normetanephrine levels are frequently elevated in patients with chronic kidney disease, particularly those on dialysis, which may lead to false positives in pheochromocytoma screening 3.
  • Another study determined that the measurement of plasma free metanephrines with LC-MS/MS is not affected by the use of β-blockers, diuretics, and ACE inhibitors, making it unnecessary to withdraw these medications before testing 4.

References

Research

Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2014

Research

Plasma free metanephrine and normetanephrine levels are increased in patients with chronic kidney disease.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.